▼ SELL
$ Value
$8.4M
Shares
289,774
Price
$29
Filed
Apr 20
Insider
Name
Gline Matthew
Title
CEO
CIK
0001750094
Roles
Director
Officer
Transaction Details
Transaction Date
2026-04-16
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
16,736,116
Footnotes
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.98 to $29.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Filing Info
Gline Matthew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-16 | ROIV | ▼ | $8.4M |
| 2026-03-31 | ROIV | F | $8.4M |
| 2026-03-30 | ROIV | M | — |
| 2026-03-30 | ROIV | F | $1.4M |
| 2026-03-30 | ROIV | M | $25.0M |
| 2025-05-20 | ROIV | F | $121K |
Other Insiders at ROIV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOMTAZEE JAMES C | — | — | 2026-04-17 |
| Fitzgerald Meghan | — | $1.9M | 2026-03-26 |
| Oren Ilan | — | — | 2026-04-17 |
|
Torti Frank
President and Vant Chair
|
— | — | 2026-03-31 |
|
Sukhatme Mayukh
President & CIO
|
— | — | 2026-03-31 |
|
Gline Matthew
CEO
|
— | — | 2026-03-31 |
|
Venker Eric
President & Immunovant CEO
|
— | $5.9M | 2026-04-20 |
| Epperly Melissa B, | — | — | 2026-04-17 |
|
Pulik Richard
CFO
|
— | — | 2026-04-20 |
|
Humes Jennifer
Chief Accounting Officer
|
— | $384K | 2026-04-20 |